In response to Covid-19, manufacturers have quickly adapted their commercial approaches. But which of those changes are permanent? What additional capabilities do organizations need to succeed in the “new normal”? What has Covid-19 shown us about weaknesses in the traditional commercial model? To understand the extent to which the pandemic…
More InsightsHealthcare Delivery and Payers Pharmaceuticals and Medical Devices
- Healthcare Delivery and Payers
- Pharmaceuticals and Medical Devices
What’s coming for the healthcare sector in 2021, and more importantly, what do pharma, medical device, and healthcare delivery executives need to do to succeed?
Even with the election over, healthcare remains in the spotlight. The Supreme Court’s decision regarding the legality of the Affordable Care Act is the next act, to be followed by action on drug pricing, surprise medical billing, and more broadly, action to lower the cost of care.
As our Numerof 2021 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about continuing to adapt to pressures on price and demands for value. You’ll continue to engage in new and different ways with healthcare delivery, physicians, regulators, public and private payers, consumers,…
As our Numerof 2021 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value while also addressing new challenges presented by the pandemic. This will create the need for changes in current roles and external…
As our Numerof 2021 US Health Insurance Outlook infographic illustrates, this year’s story for health insurance will be about dramatically changing roles and relationships. You’ll engage in new and different ways with providers, consumers, employers, regulators, medical device makers and pharmaceutical manufacturers. All this will come in the context of…